Table 1.
Histotype | CK | αFP | βhCG | CD117 | PLAP | CD30 | OCT4 | SALL4 | Glypican 3 | NANOG | LIN28 | SOX2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
SE | Nega | Neg | Negb | Pos | Pos | Neg | Pos | Pos | Neg | Pos | Pos | Neg |
EC | Pos | Neg/Pos | Negb | Neg | Neg | Pos | Pos | Pos | Neg/Pos | Pos | Pos/Neg | Pos |
YSC | Pos | Pos | Negb | Neg | Neg/Pos | Neg/Pos | Neg | Pos | Pos | Neg | Neg | Neg |
PT | Pos | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg |
CHC | Pos | Neg | Pos | Neg | Neg | Neg | Neg | Posc | Pos | Neg | Neg | Neg/Pos |
Abbreviations: αFP, alpha fetoprotein; β‐hCG, beta human chorionic gonadotropin; CHC, choriocarcinoma; EC, embryonal carcinoma; PT, pure teratoma; SE, seminoma; YSC, yolk sac tumor.
Dot‐like positivity can be observed.
Syncytiotrophoblastic cells are positive, if present.
Positive in mononuclear trophoblastic cells.